Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

Autor: Marcel Kool, Fabian Kratochwil, Stefan Gröschel, Stefan M. Pfister, Dominik Sturm, Josef Zamecnik, Maia Segura Wang, Nada Jabado, Paul A. Northcott, Peter Lichter, Peter van Sluis, Carl Hermann, Susanne Bens, Pascal Johann, Andrea Wittmann, Reinhard Schneppenheim, Katja Beck, Ulrich Schüller, Kornelius Kerl, Florian Oyen, Sebastian Brabetz, Michael A. Grotzer, Marc Zapatka, Jaume Mora, Jan Koster, Laura Sieber, Richard Volckmann, Eleonora Aronica, David Sumerauer, Marina Rhyzova, Annie Huang, David T.W. Jones, Roland Eils, Stefan Wolf, Serap Erkek, Susanne Gröbner, Lukas Chavez, Anna Marta Maria Bertoni, Michael C. Frühwald, Christina Geörg, Rogier Versteeg, Volker Hovestadt, Till Milde, Michael D. Taylor, Andreas von Deimling, Torsten Pietsch, Reiner Siebert, David Capper, Jan O. Korbel, Martin Hasselblatt, Tarek Shalaby, Bernhard Radlwimmer, Olaf Witt, Ivo Buchhalter, Andrey Korshunov, Andreas E. Kulozik, Amar Gajjar, Martin Ebinger
Přispěvatelé: Cellular and Computational Neuroscience (SILS, FNWI), Oncogenomics, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA -Cancer Center Amsterdam, ANS - Cellular & Molecular Mechanisms, Pathology, APH - Amsterdam Public Health, Other departments
Rok vydání: 2016
Předmět:
Zdroj: Cancer Cell
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Cancer Cell, 29(3), 379-393. Cell Press
Cancer cell, 29(3), 379-393. Cell Press
ISSN: 1535-6108
Popis: Atypical teratoid/rhabdoid tumor (ATRT) is one of the most common brain tumors in infants. Although the prognosis of ATRT patients is poor, some patients respond favorably to current treatments, suggesting molecular inter-tumor heterogeneity. To investigate this further, we genetically and epigenetically analyzed 192 ATRTs. Three distinct molecular subgroups of ATRTs, associated with differences in demographics, tumor location, and type of SMARCB1 alterations, were identified. Whole-genome DNA and RNA sequencing found no recurrent mutations in addition to SMARCB1 that would explain the differences between subgroups. Whole-genome bisulfite sequencing and H3K27Ac chromatin-immunoprecipitation sequencing of primary tumors, however, revealed clear differences, leading to the identification of subgroup-specific regulatory networks and potential therapeutic targets.
Databáze: OpenAIRE